HIV-1 entry inhibitors in the side pocket

被引：84
|
作者：
Sodroski, JG [1 ]
机构：
[1] Harvard Univ, Sch Med, Dept Canc Immunol & AIDS, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA
[4] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA
来源：
CELL | 1999年 / 99卷 / 03期
关键词：
D O I：
10.1016/S0092-8674(00)81655-4
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
[No abstract available]
引用
收藏
页码：243 / 246
页数：4
相关论文
共 50 条
  • [21] Non-peptide entry inhibitors of HIV-1 that target the gp41 coiled coil pocket
    Stewart, Kent D.
    Huth, Jeffrey R.
    Ng, Teresa I.
    McDaniel, Keith
    Hutchinson, Rebecca Newlin
    Stoll, Vincent S.
    Mendoza, Renaldo R.
    Matayoshi, Edmund D.
    Carrick, Robert
    Mo, HongMei
    Severin, Jean
    Walter, Karl
    Richardson, Paul L.
    Barrett, Leo W.
    Meadows, Robert
    Anderson, Steve
    Kohlbrenner, William
    Maring, Clarence
    Kempf, Dale J.
    Molla, Akhter
    Olejniczak, Edward T.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (02) : 612 - 617
  • [22] HIV-1 Entry Inhibitors: A Review of Experimental and Computational Studies
    Rad, Tahereh Mostashari
    Saghaie, Lotfollah
    Fassihi, Afshin
    CHEMISTRY & BIODIVERSITY, 2018, 15 (10)
  • [23] Resistance against inhibitors of HIV-1 entry into target cells
    Kramer, Victor G.
    Wainberg, Mark A.
    FUTURE VIROLOGY, 2015, 10 (02) : 97 - 112
  • [24] Co-receptor antagonists as HIV-1 entry inhibitors
    Shaheen, F
    Collman, RG
    CURRENT OPINION IN INFECTIOUS DISEASES, 2004, 17 (01) : 7 - 16
  • [25] Potent D-peptide inhibitors of HIV-1 entry
    Welch, Brett D.
    VanDemark, Andrew P.
    Heroux, Annie
    Hill, Christopher P.
    Kay, Michael S.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (43) : 16828 - 16833
  • [26] Structure Optimization of Aloperine Derivatives as HIV-1 Entry Inhibitors
    Dang, Zhao
    Xie, Hua
    Zhu, Lei
    Zhang, Qjngye
    Li, Zhijun
    Huang, Li
    Chen, Chin-Ho
    ACS MEDICINAL CHEMISTRY LETTERS, 2017, 8 (11): : 1199 - 1203
  • [27] Updating the Use of Synthetic Peptides as Inhibitors of HIV-1 Entry
    Jose Gomara, Maria
    Haro, Isabel
    CURRENT MEDICINAL CHEMISTRY, 2014, 21 (10) : 1188 - 1200
  • [28] HIV-1 entry inhibitors: new targets, novel therapies
    Pierson, TC
    Doms, RW
    IMMUNOLOGY LETTERS, 2003, 85 (02) : 113 - 118
  • [29] HIV-1 entry inhibitors: recent development and clinical use
    Henrich, Timothy J.
    Kuritzkes, Daniel R.
    CURRENT OPINION IN VIROLOGY, 2013, 3 (01) : 51 - 57
  • [30] Current Status of the Pharmacokinetics and Pharmacodynamics of HIV-1 Entry Inhibitors and HIV Therapy
    Xu, Fengyan
    Acosta, Edward P.
    Liang, Liyu
    He, Yingchun
    Yang, Juan
    Kerstner-Wood, Corenna
    Zheng, Qingshang
    Huang, Jihan
    Wang, Kun
    CURRENT DRUG METABOLISM, 2017, 18 (08) : 769 - 781
12345